טוען...
Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis
Development of an improved tuberculosis (TB) vaccine is a high worldwide public health priority. Bacillus Calmette-Guerin (BCG), the only licensed TB vaccine, provides variable efficacy against adult pulmonary TB, but why this protection varies is unclear. Humans are regularly exposed to non-tubercu...
שמור ב:
| הוצא לאור ב: | J Infect Dis |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Oxford University Press
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6736075/ https://ncbi.nlm.nih.gov/pubmed/31165861 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz285 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|